In the ENBALV study, it was inconclusive whether edoxaban is a better treatment than warfarin for patients with early ...

In the phase 3 SUMMIT trial, tirzepatide, was found to reduce the risk for worsening heart failure in patients with preserved ...

Results from the GLORIOUS trial indicated that exenatide did not decrease mortality or severe organ injury among patients who ...

An analysis of more than 5,300 patients with MS shows that access to early treatment in MS varies, though those with ...

I Infusions and Burden of Ischemic Events After Acute Myocardial Infarction: Insights From the AEGIS-II Trial,” published in ...

Winter affects sleep schedules through daylight shifts, reduced sunlight, and seasonal illness, negatively impacting sleep ...

The following is a summary of “Hyperthermic Intraperitoneal Chemotherapy in Platinum-Sensitive Recurrent Ovarian Cancer: A ...

The following is a summary of “Characterization of changes in the resting-state intrinsic network in patients with diabetic ...

The following is a summary of “Association between early anti-cytomegalovirus therapy and the incidence of chronic ...

The following is a summary of “ECMO Survivors’ Reflections on Their ICU Experience and Recovery,” published in the October ...

The following is a summary of “Associations of Self-Reported Race, Social Determinants of Health, and Polygenic Risk With ...

An intensive blood pressure (BP)-lowering treatment strategy led to fewer major cardiovascular events than a standard BP-lowering treatment strategy in patients with type 2 diabetes and an elevated ...